MV
| |
Macquarie VIP Growth & Income SeriesMutual Fund | |
Macquarie VIP Growth & Income Series | |
Last update 2025-02-26 | 70 Stocks (6 new) |
Value $708.00 Mil | Turnover 12 % |
Macquarie VIP Growth & Income ... Top Holdings of 2024-12-31
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
XOM | Exxon Mobil Corp | 320,557 | 34,482.3 | -3.69% | 4.870 | -0.21% | 0.010 | -2.22% | -1.30% | 449,366.0 | Oil & Gas | |
CSCO | Cisco Systems Inc | 518,691 | 30,706.5 | +2.45% | 4.340 | +0.10% | 0.010 | +4.87% | +13.10% | 261,597.5 | Hardware | |
GILD | Gilead Sciences Inc | 286,001 | 26,417.9 | -2.62% | 3.730 | -0.09% | 0.020 | -2.40% | +22.60% | 139,892.3 | Drug Manufacturers | |
PM | Philip Morris International Inc | 216,655 | 26,074.4 | -19.64% | 3.680 | -0.94% | 0.010 | +19.40% | +52.33% | 282,865.9 | Tobacco Products | |
BMY | Bristol-Myers Squibb Co | 449,558 | 25,427.0 | +9.30% | 3.590 | +0.31% | 0.020 | -18.69% | -12.53% | 98,518.3 | Drug Manufacturers | |
MCK | McKesson Corp | 41,158 | 23,456.4 | +24.53% | 3.310 | +0.65% | 0.030 | +11.21% | +25.35% | 89,111.3 | Medical Distribution | |
CI | The Cigna Group | 78,699 | 21,731.9 | -3.37% | 3.070 | -0.14% | 0.030 | -0.62% | +14.15% | 83,396.6 | Healthcare Plans | |
MRK | Merck & Co Inc | 202,187 | 20,113.6 | +12.09% | 2.840 | +0.31% | 0.010 | -15.26% | -19.93% | 198,296.1 | Drug Manufacturers | |
PNC | PNC Financial Services Group Inc | 91,338 | 17,614.5 | 0% | 2.490 | 0% | 0.020 | +0.84% | -5.64% | 70,660.1 | Banks | |
WFC | Wells Fargo & Co | 248,355 | 17,444.5 | +406.63% | 2.460 | +1.97% | 0.010 | +5.64% | +9.81% | 248,391.7 | Banks |
Macquarie VIP Growth & Income Series's Historical Top Holdings Breakdowns
Macquarie VIP Growth & Income Series's Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
LMT | Lockheed Martin Corp | 2024-12-31 | New Buy | +2.02% | 479.66 ($544.15) 614.61 | $481.69 | -11.48% | New holding | 29,452 | 29,452 | |
WFC | Wells Fargo & Co | 2024-12-31 | Add | +1.97% | 54.98 ($68.48) 77.35 | $76.33 | 11.46% | Add 406.63% | 248,355 | 199,334 | |
C | Citigroup Inc | 2024-12-31 | Add | +1.88% | 61.31 ($67.49) 72.5 | $78.26 | 15.96% | Add 630.54% | 218,949 | 188,978 | |
MPC | Marathon Petroleum Corp | 2024-12-31 | Reduce | -1.86% | 131.65 ($152.44) 174.84 | $160.12 | 5.04% | Reduce -74.13% | 27,234 | -78,022 | |
ABBV | AbbVie Inc | 2024-12-31 | New Buy | +1.38% | 164.99 ($183.65) 203.87 | $189.83 | 3.37% | New holding | 54,864 | 54,864 | |
BLDR | Builders FirstSource Inc | 2024-12-31 | Sold Out | -1.25% | 142.93 ($176.68) 198.25 | $111.63 | -36.82% | Sold Out | 0 | -43,970 | |
PM | Philip Morris International Inc | 2024-12-31 | Reduce | -0.94% | 118.38 ($126.25) 133.06 | $181.73 | 43.94% | Reduce -19.64% | 216,655 | -52,936 | |
EMR | Emerson Electric Co | 2024-12-31 | Reduce | -0.70% | 108.13 ($121.48) 134.33 | $123.51 | 1.67% | Reduce -48.52% | 46,774 | -44,079 | |
MCK | McKesson Corp | 2024-12-31 | Add | +0.65% | 482.27 ($561.01) 628.5 | $712.89 | 27.07% | Add 24.53% | 41,158 | 8,108 | |
CVS | CVS Health Corp | 2024-12-31 | Add | +0.64% | 43.78 ($56.01) 67.46 | $63.58 | 13.52% | Add 36.47% | 379,718 | 101,465 |
Macquarie VIP Growth & Income Series Total Holding History ($B)
Macquarie VIP Growth & Income Series's Asset Allocation
Macquarie VIP Growth & Income Series Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
Macquarie VIP Growth & Income Series's Hypothetical Growth since 2024-12-31
Macquarie VIP Growth & Income Series's Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
Macquarie VIP Growth & Income Series's Holdings Heat Map
Size field:
Macquarie VIP Growth & Income Series's Holdings Bubble Chart
Macquarie VIP Growth & Income Series News
- 1